Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Current pharmaceutical design - 1 Jan 2015

Lozano Reymundo, Martinez-Cerdeno Veronica, Hagerman Randi J

Abstract excerpt

Fragile X spectrum disorder (FXSD) includes: fragile X syndrome (FXS), fragile X-associated tremor ataxia syndrome (FXTAS) and fragile X-associated primary ovarian insufficiency (FXPOI), as well as other medical, psychiatric and neurobehavioral problems associated with the premutation and gray zone alleles. FXS is the most common monogenetic cause of autism (ASD) and intellectual disability (ID). The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Fragile X Mental Retardation Protein

Share to Fragile X Syndrome

Share to gamma-Aminobutyric Acid

Share to FMR1 gene

Share to Molecular Targeted Therapy

Source

Open in PubMed Open full text

Identifiers

PMID: 26365141
DOI: 10.2174/1381612821666150914121038
PMCID: PMC4830341

Genes

FMR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.PMID 26365141Read ↗

Advances in the treatment of fragile X syndrome.Semantic proximity Read ↗

Lessons from fragile X regarding neurobiology, autism, and neurodegeneration.Semantic proximity Read ↗

The psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome.Semantic proximity Read ↗

Investigating potential treatment strategies and underlying mechanisms in the Fragile X Syndrome mouse and rat modelsSemantic proximity Read ↗

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment.Semantic proximity Read ↗

The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome.Semantic proximity Read ↗

Advances in understanding fragile X syndrome and related disorders.Semantic proximity Read ↗

Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome.Semantic proximity Read ↗

Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications.Semantic proximity Read ↗

Fragile X syndrome: A review of clinical managementSemantic proximity Read ↗

Fragile X syndrome: from targets to treatments.Semantic proximity Read ↗

The quest for targeted therapy in fragile X syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.